Brandt, Margot
Gokden, Alper
Ziosi, Marcello
Lappalainen, Tuuli https://orcid.org/0000-0002-7746-8109
Funding for this research was provided by:
National Institutes of Health (R01MH106842, R01GM122924)
Article History
Received: 20 September 2019
Accepted: 19 August 2020
First Online: 11 September 2020
Ethics approval and consent to participate
: Not applicable
: Not applicable
: T.L. is a scientific advisory board member of Variant Bio and Goldfinch Bio and owns stock in Variant Bio. M.B. is now an employee of <i>Nature Communications</i>, a journal from the same publisher; she did not have any access to or involvement with the editorial process at <i>Genome Medicine</i>. The remaining authors declare that they have no competing interests.